Pharma M&A: The top high value deals in 2023
From Pfizer’s Seagen acquisition to Sanofi’s deal with Provention Bio, Pharmaceutical Technology lists the highest value pharma deals that were completed in 2023.
From Pfizer’s Seagen acquisition to Sanofi’s deal with Provention Bio, Pharmaceutical Technology lists the highest value pharma deals that were completed in 2023.
What's Your Reaction?
